Bristol-Myers Squibb Co. (BMY) News Headlines

▮ More

Date

Headline

10/26/2020 1:45:58 AM Biotech Stocks Facing FDA Decision In November 2020

10/23/2020 2:27:15 AM Sensyne Health Signs Research Collaboration Agreement With Bristol Myers Squibb

10/8/2020 1:48:40 AM Evotec, Bristol Myers Expand Neuroscience Partnership; Evotec Gains Milestone Payment

10/8/2020 1:40:31 AM Evotec Gets $6 Mln Payment From Bristol Myers Following Decision To Expand Portfolio For Neurodegenerative Diseases

10/8/2020 1:39:50 AM Evotec SE Receives $6 Mln Payment From Bristol Myers Squibb

10/7/2020 10:12:52 AM Opdivo Plus Chemotherapy As Neoadjuvant Treatment In Resectable NSCLC Trial Hits Key Goal, Says BMY

10/7/2020 8:23:48 AM Canada Approves Bristol-Myers' Zeposia To Treat Relapsing Remitting Multiple Sclerosis

10/7/2020 8:02:07 AM Bristol Myers Squibb: Health Canada Approves ZEPOSIA For Patients With Relapsing Remitting Multiple Sclerosis

10/5/2020 9:09:53 AM Bristol Myers Snaps Up MyoKardia For $225/Share

10/5/2020 7:16:00 AM Bristol Myers Squibb To Buy MyoKardia For $13.1 Bln In Cash - Quick Facts

10/5/2020 6:50:03 AM Bristol-Myers Squibb Investor Conference Call At 8:00 AM ET

10/5/2020 6:33:37 AM Bristol Myers Squibb To Acquire MyoKardia For $13.1 Bln Cash

10/5/2020 5:17:06 AM FDA Approves Drug Combination To Treat Mesothelioma

9/29/2020 8:26:20 AM Bristol Myers, Acceleron Pharma Announce Health Canada Approval Of Reblozyl

9/29/2020 7:05:12 AM Bristol Myers Squibb Canada And Acceleron Pharma Announce Health Canada Approves REBLOZYL

9/17/2020 8:18:31 AM Celgene, Dr. Reddy's Reach Settlement Agreement On Patents For REVLIMID Capsules

9/15/2020 7:32:29 AM Bristol Myers Exercises Option To Exclusive License To Cell Therapy Candidate Based On Obsidian's CytoDRiVE Technology

8/26/2020 8:45:32 PM Biotech Stocks Facing FDA Decision In September

8/6/2020 7:47:07 AM Bristol-Myers Slips To Loss In Q2, But Results Top Estimates

8/6/2020 7:05:45 AM Bristol Myers Squibb Q2 GAAP Loss Per Share $0.04 And Non-GAAP EPS $1.63